This text investigates the nature, measurement, and clinical implications of cognitive impairment in patients diagnosed with major depressive disorder. The authors, experts in mood disorders and psychopharmacology, synthesize current clinical data to bridge the gap between neurobiological pathophysiology and practical patient management. The work establishes a framework for integrating cognitive assessment into standard psychiatric care protocols.

Experts identify this volume as a concise, high-utility resource for clinicians seeking to integrate cognitive screening into their practice. Readers frequently note the clinical focus of the prose, which prioritizes actionable assessment tools over purely theoretical neuroscientific discourse.